YOLFTbeta
Proteome Sciences PLC

Proteome Sciences PLC

PRM · LSE · Healthcare / Diagnostics & Research

1.36GBX+0.07 (+5.02%)

Price History

Full chart

Market Stats

Previous Close1.30
Open1.36
Day Range1.36 – 1.61
52-Week Range1.11 – 4.40
Volume6.15K
Market Cap4.91M
P/E (TTM)0.00
Forward P/E35.71
EPS-0.01
Dividend Yield0.00%
Beta0.15
50-Day Avg1.59
200-Day Avg1.79

About

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM); SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. Proteome Sciences plc was incorporated in 1993 and is based in Cobham, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Christopher Donovan James Pearce Dip., MSI
  • Employees32
  • HeadquartersCoveham House, Cobham, United Kingdom, KT11 3EP, UK
  • Websitehttps://www.proteomics.com

Leadership

  • Mr. Christopher Donovan James Pearce Dip., MSIExecutive Chairman · b. 1953
  • Mr. Richard Paul DennisChief Commercial Officer & Executive Director · b. 1958
  • Mr. Stefan FuhrmannFinance Director
  • David Van MeterChief Operations Officer
  • Victoria Joanna BirseCompany Secretary

Financials

Income Statement

Currency: GBP1994-10-311994-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue--------171.40K170.05K72.97K16.20K68.47K265.59K849.49K1.31M9.98M1.02M1.15M2.14M1.56M1.88M2.74M3.38M3.05M4.63M4.71M5.12M7.78M5.03M4.89M3.76M
Growth (%)----------0.79%-57.09%-77.80%+322.65%+287.90%+219.85%+53.70%+664.34%-89.77%+12.91%+85.32%-26.96%+20.59%+45.80%+23.18%-9.79%+51.98%+1.68%+8.74%+51.83%-35.37%-2.80%-23.14%
Cost of Revenue--------131.75K82.92K1.26M1.09M339.61K292.01K400.17K484.74K273.29K257.27K385.47K592.66K604.55K791.00K1.20M1.18M1.18M1.70M2.17M2.17M3.01M3.87M5.05M4.76M
Gross Profit--------39.65K87.13K-1.19M-1.07M-271.14K-26.42K449.32K820.96K-273.29K763.89K767.50K1.54M956.17K1.09M1.55M2.20M1.87M2.93M2.54M2.96M4.77M1.16M-167.00K-1.01M
Gross Margin--------23.13%51.24%-1632.63%-6604.59%-396.01%-9.95%52.89%62.88%-2.74%74.81%66.57%72.26%61.26%57.97%56.41%65.09%61.30%63.27%53.99%57.67%61.27%23.13%-3.42%-26.81%
Operating Expense--------4.24M6.97M3.91M5.46M5.05M5.27M4.71M4.69M-5.15M5.11M5.01M4.92M4.97M4.19M4.22M4.00M3.24M2.65M2.02M2.44M3.28M2.63M2.11M1.66M
Operating Income-24.00K-24.00K-1.63M-1.68M-2.00M-1.26M-1.21M-2.03M-4.20M-6.88M-5.10M-6.53M-5.32M-5.30M-4.26M-3.87M4.87M-4.34M-4.24M-3.38M-4.02M-3.10M-2.67M-1.80M-1.37M279.00K526.00K512.00K1.49M-1.47M-2.27M-2.67M
Operating Margin---------2449.35%-4047.29%-6984.40%-40289.27%-7769.94%-1994.44%-502.04%-296.08%48.84%-425.13%-367.83%-157.97%-257.29%-164.51%-97.49%-53.14%-44.83%6.02%11.16%9.99%19.15%-29.24%-46.53%-70.98%
EBITDA-24.00K-24.00K-1.55M-1.44M-1.79M-1.16M-1.33M-1.95M-4.07M-6.10M-4.43M-5.45M-5.03M-5.12M-4.09M-3.71M168.14K-4.14M-4.07M1.12B950.98M1.06B-2.12M-1.46M-1.14M368.00K691.00K625.00K2.13M-1.14M-1.52M-1.74M
EBITDA Margin---------2371.65%-3585.16%-6071.37%-33654.68%-7343.93%-1927.03%-481.52%-284.15%1.68%-405.01%-353.40%52493.79%60932.61%56424.23%-77.33%-43.31%-37.32%7.94%14.66%12.20%27.31%-22.61%-31.02%-46.33%
Net Income-20.00K-20.00K-1.59M-1.50M-1.85M-1.23M-1.41M-1.98M-4.11M-6.78M-5.20M-6.90M-5.64M-5.25M-4.62M-4.01M4.56M-3.96M-4.25M-3.15M-3.57M-2.72M-2.28M-2.50M-1.31M149.00K295.00K72.00K1.32M-2.44M-3.41M-3.06M
Net Income Margin---------2397.66%-3987.77%-7125.02%-42572.25%-8233.93%-1977.47%-544.38%-307.10%45.72%-387.53%-368.93%-147.39%-228.52%-144.42%-83.09%-73.88%-43.06%3.22%6.26%1.41%17.03%-48.59%-69.70%-81.50%
R&D--588.00K760.00K905.00K560.00K695.00K721.00K1.77M3.55M3.48M3.13M2.87M3.14M2.92M2.96M2.58M2.28M2.43M1.92M1.56M1.25M1.07M441.00K441.00K355.00K202.00K287.00K376.00K637.00K606.00K-
R&D as % of Total Revenue--------1033.26%2088.80%4764.92%19332.22%4190.84%1183.85%343.57%226.74%25.85%223.64%210.77%89.83%99.92%66.31%39.18%13.05%14.46%7.66%4.29%5.60%4.83%12.67%12.40%-
Interest Expense4.00K4.00K4.00K2.00K4.00K6.00K21.00K32.00K11.02K5.90K1.94K88236.64K302.10K516.06K331.74K299.37K192.78K199.62K225.35K241.84K250.00K257.00K246.00K289.00K335.00K304.00K294.00K473.00K797.00K895.00K925.00K
Interest Expense % of Total Revenue--------6.43%3.47%2.66%5.44%53.51%113.74%60.75%25.41%3.00%18.88%17.31%10.55%15.50%13.28%9.37%7.28%9.48%7.23%6.45%5.74%6.08%15.85%18.31%24.63%

Balance Sheet

Currency: GBP1994-10-311994-12-311995-12-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets418.00K418.00K1.83M606.00K3.42M1.89M802.00K4.21M3.75M13.83M14.43M10.34M9.57M6.40M6.63M6.44M6.20M15.60M10.91M6.95M1.34T1.36T1.12T1.21T1.13T1.13T1.14T1.35T1.38T1.51T11.46M9.21M8.26M
Total Liabilities688.00K688.00K480.00K285.00K551.00K862.00K697.00K1.57M1.24M1.98M2.58M1.54M1.72M3.81M8.80M12.07M15.44M8.38M7.61M7.72M1.28T1.29T1.05T119.08B1.07T1.07T1.07T1.28T1.31T1.44T14.52M15.72M17.79M
Total Equity-270.00K-270.00K788.00K-242.00K2.87M1.03M105.00K2.64M2.50M11.84M11.84M8.80M7.85M2.59M-2.17M-5.62M-9.24M7.22M3.30M-766.53K55.38B59.57B59.81B64.87B63.91B62.56B64.43B65.80B69.05B68.29B-3.07M-6.52M-9.53M
Cash353.00K353.00K1.60M368.00K3.00M1.45M447.00K3.30M1.06M906.50K1.37M625.94K687.00K304.00K530.00K274.00K131.00K9.54M4.06M858.25K77.03B74.03B82.19B106.95B175.34B180.03B153.39B193.69B240.31B252.89B2.03M1.13M781.00K
Total Debt--39.00K20.00K1.00K23.00K63.00K402.00K183.00K100.00K34.00K--1.64M5.94M9.09M11.79M6.33M6.53M6.73M305.14B288.70B115.65B119.08B114.29B127.18B128.01B120.95B138.58B139.92B13.47M14.52M15.77M
Net Debt-353.00K-353.00K-1.56M-348.00K-3.00M-1.43M-384.00K-2.90M-878.00K-806.50K-1.33M-625.94K-687.00K1.33M5.41M8.81M11.66M-3.21M2.46M5.87M228.10B214.67B33.47B12.13B-61.05B-52.84B-25.37B-72.74B-101.73B-112.98B11.45M13.39M14.99M

Cash Flow

Currency: GBP1994-10-311996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-809.00K-1.71M-1.29M-1.54M-1.25M-1.14M-1.55M-3.27M-4.88M-3.77M-4.77M-3.61M-4.09M-4.12M-2.97M4.00M-5.17M-3.35M-11.55B-6.27B46.63B-31.70B55.47B-14.78B-21.45B1.58M793.00K2.14M-481.00K-826.00K-46.00K
Investing Cash Flow50.00K-52.00K-104.00K-10.00K-45.00K-234.00K1.45M-2.60M-1.44M873.00K-281.00K-313.00K-13.00K-22.00K-10.00K-617.00K-174.00K-5.97K-22.64B8.43B-6.55B36.71B3.50B1.25B-23.96B-18.38B4.27B-21.67B-424.00K-224.00K-97.00K
Financing Cash Flow1.11M399.00K4.09M-8.00K368.00K4.54M-52.00K2.58M6.53M2.16M5.11M1.64M4.30M3.67M2.70M6.06M-23.93K-7.48B-5.12B-33.69B42.07B6.30B17.18B21.64B-146.00K-400.00K-209.00K-1.06M151.00K-204.00K
Capital Expenditure052.00K104.00K22.00K45.00K8.00K488.00K61.00K4.00K2.12M181.00K358.00K23.00K31.00K11.00K631.00K206.00K14.60K736.00M691.00M1.93B1.71B1.46B1.40B1.79B1.32B1.72B1.75B237.00K224.00K97.00K
Free Cash Flow-809.00K-1.76M-1.39M-1.56M-1.30M-1.15M-2.04M-3.33M-4.88M-5.89M-4.95M-3.96M-4.12M-4.15M-2.98M3.37M-5.37M-3.37M-12.29B-6.96B44.70B-33.40B54.02B-16.18B-23.24B-9.07B8.80B2.14B-718.00K-1.05M-143.00K
Dividends Paid-------------------------936.00M1.36B1.93B2.19B--
FCF to OCF100.00%103.04%108.09%101.43%103.59%100.70%131.40%101.86%100.08%156.28%103.80%109.93%100.56%100.75%100.37%84.24%103.99%100.44%106.37%111.03%95.87%105.39%97.38%109.49%108.36%-572836.39%1109962.17%99813.08%149.27%127.12%310.87%
Dividend Paid to FCF--------------------------10.32%15.45%90.50%-305710.31%--

Earnings

Report DateMay 29, 2014May 31, 2016Sep 15, 2016May 16, 2017Sep 13, 2017Mar 26, 2018Jul 24, 2018Apr 2, 2019Jul 25, 2019Mar 31, 2020Aug 10, 2020Apr 12, 2021Jul 29, 2021Mar 31, 2022Aug 4, 2022Apr 4, 2023Apr 18, 2025Sep 11, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00-
EPS Actual0.00-0.01-0.010.000.000.000.000.000.000.000.000.000.000.000.000.000.00-0.01
Surprise------------------
Timing---------------Pre-market-Pre-market

Key Statistics & Ratios

Market Cap4.91M
Enterprise Value20.09M
Trailing P/E0.00
Forward P/E35.71
PEG Ratio0.00
Price / Sales1.30
Price / Book974.67
EPS-0.01
Book Value-0.032
Revenue (TTM)3.77M
Gross Profit (TTM)31.00K
EBITDA-2.04M
Profit Margin-61.46%
Operating Margin-66.22%
Return on Equity0.00%
Return on Assets-17.82%
Shares Outstanding350.72M
Shares Float219.76M
Beta0.15
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 11, 2010459:455
  • Mar 29, 2000315:298
  • Feb 14, 199787:86